There is an ever-increasing body of literature examining gene–environment interactions in psychiatry, reflecting a widespread belief that such studies will aid identification of novel risk factors for disease, increase understanding about underlying pathological mechanisms, and aid identification of high-risk groups for targeted interventions. In this article we discuss to what extent studies of gene–environment interactions are likely to lead to any such benefits in the future.